drugset / Trial / NCT03345316

Study of FFI-1010 in Pediatric Kidney Disease

NCT03345316 ↗

Phase 3 Completed 60 enrolled Fuji Yakuhin Co., Ltd.
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is revealing that the ratio of creatinine clearance (Ccr) to inulin clearance (Cin) measuring at the same time is more than 1.2.

Timeline

Start
2017-11-01
Primary completion
2019-11-01
Completion
2019-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject FFI-1010 Unknown — Intravenous

Indications

No indication recorded.